Publications scientifiques

2467 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2022

JOURNALClinical genitourinary cancer

PREMIER AUTEUREscudier B

TITREManagement and Health Resource Use of Patients With Metastatic Renal Cell Carcinoma treated With Systemic Therapy Over 2014-2017 in France: A National Real-World Study.

ANNÉE2022

JOURNALJournal of plastic, reconstructive & aesthetic surgery : JPRAS

PREMIER AUTEURFauconnier MB

TITREComparison of postoperative complications following conventional latissimus dorsi flap versus muscle-sparing latissimus dorsi flap breast reconstruction.

ANNÉE2022

JOURNALJournal of clinical oncology : official journal of the American Society of Clinical Oncology

PREMIER AUTEURFornecker LM

TITREBrentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.

ANNÉE2022

JOURNALScience advances

PREMIER AUTEURAbu El Maaty MA

TITREHypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression.

ANNÉE2022

JOURNALFrontiers in oncology

PREMIER AUTEURGrave A

TITRELong-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma.

ANNÉE2022

JOURNALFrontiers in immunology

PREMIER AUTEURMarguier A

TITRETIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition.

ANNÉE2022

JOURNALCancers

PREMIER AUTEURRoussel X

TITREPlasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.

ANNÉE2022

JOURNALPublic health

PREMIER AUTEURBalamou C

TITREImpact of tomosynthesis on the evolution of the cancer detection rate in the French National Breast Cancer Screening Program.

ANNÉE2022

JOURNALDiagnostics (Basel, Switzerland)

PREMIER AUTEURGirard S

TITREWhen Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.

ANNÉE2022

JOURNALFrontiers in oncology

PREMIER AUTEURRebucci-Peixoto M

TITREA Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study.

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques